Novel therapy for children with chronic hormone deficiency provides lifeline for parents

Apr 12, 2019

  • Alkindi® is the first replacement therapy specially designed for infants, children and adolescents with paediatric adrenal insufficiency
  • Adrenal insufficiency is caused by a lack of the stress hormone cortisol – which can be fatal
  • This new therapy, which has been developed by University of Sheffield spin-out company Diurnal, has been granted market authorisation by the European Medicine Agency.

Read more

Recent Blog Posts

Cambridge Brain and Behaviour Study – Volunteers Wanted!

Cambridge Brain and Behaviour Study – Volunteers Wanted!

The CamBABS team at Cambridge University and Cambridge University Hospitals is looking for men and women with classic CAH (either salt wasting or simple virilising) to help with their research. They are conducting a study aimed at understanding how hormone exposure...

Intramuscular Injector Survey

Intramuscular Injector Survey

"Exploring a solution to improve the safety of patients with Adrenal and Pituitary conditions in emergency situations". One of our members is performing a study into how those with adrenal and pituitary conditions can be safer in emergency situations. We're sure...